Delivery Order SPE2DB20D2014-SPE2DB24FB21S

Award Date 3/4/24
Potential Completion Date 3/5/24
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $17,941.81 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of April 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
This firm fixed price delivery order for $2,177.74 was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The order is for ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through DLA contracts. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $48,872.58 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period through April 10, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,063.59 order is for the supply of ELIQUIS 5 MG TABLET 60S and has a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,782.76 firm fixed-price contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication, with a completion date of February 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,390.95 firm-fixed-price delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a period of performance through May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,221.47 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 13, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,072.56 Firm Fixed Price Delivery Order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The $6,128.85 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,078.11 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S and has a completion date of June 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB21S
    Delivery Order

This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $17,692.57 order is for the supply of ELIQUIS 5 MG TABLET 60S, with a performance period through March 5, 2024.

Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to supply medications, medical supplies, and related distribution services in support of military treatment programs and facilities.

Generated 6/3/24, 9:03 AM